CVS
Income statement / Annual
Last year (2023), CVS Health Corporation's total revenue was $357.78 B,
an increase of 10.95% from the previous year.
In 2023, CVS Health Corporation's net income was $8.34 B.
See CVS Health Corporation,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$357.78 B
|
$322.47 B
|
$292.11 B
|
$268.71 B
|
$256.78 B
|
$194.58 B
|
$184.79 B
|
$177.55 B
|
$153.29 B
|
$139.37 B
|
| Cost of Revenue |
$303.35 B |
$267.97 B |
$239.99 B |
$219.66 B |
$211.25 B |
$163.04 B |
$156.26 B |
$148.71 B |
$126.76 B |
$114.00 B |
| Gross Profit |
$54.43 B |
$54.50 B |
$52.12 B |
$49.05 B |
$45.53 B |
$31.54 B |
$28.53 B |
$28.83 B |
$26.53 B |
$25.37 B |
| Gross Profit Ratio |
0.15 |
0.17 |
0.18 |
0.18 |
0.18 |
0.16 |
0.15 |
0.16 |
0.17 |
0.18 |
| Research and Development
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Other Expenses |
$40.69 B |
$46.55 B |
$38.81 B |
$35.14 B |
$33.54 B |
$27.52 B |
$18.99 B |
$18.45 B |
$17.05 B |
$16.57 B |
| Operating Expenses |
$40.69 B |
$46.55 B |
$38.81 B |
$35.14 B |
$33.54 B |
$27.52 B |
$18.99 B |
$18.45 B |
$17.05 B |
$16.57 B |
| Cost And Expenses |
$344.03 B |
$314.51 B |
$278.80 B |
$254.80 B |
$244.79 B |
$190.56 B |
$175.25 B |
$167.16 B |
$143.82 B |
$130.57 B |
| Interest Income |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$21.00 M |
$20.00 M |
$21.00 M |
$15.00 M |
| Interest Expense |
$2.66 B |
$2.29 B |
$2.50 B |
$2.91 B |
$3.04 B |
$2.62 B |
$1.06 B |
$1.08 B |
$859.00 M |
$615.00 M |
| Depreciation &
Amortization |
$4.37 B
|
$4.22 B
|
$4.49 B
|
$4.44 B
|
$4.37 B
|
$2.72 B
|
$2.48 B
|
$2.48 B
|
$2.09 B
|
$1.93 B
|
| EBITDA |
$18.20 B
|
$12.35 B
|
$17.53 B
|
$17.12 B
|
$16.40 B
|
$6.74 B
|
$11.81 B
|
$12.19 B
|
$11.57 B
|
$10.22 B
|
| EBITDA Ratio |
0.05 |
0.06 |
0.07 |
0.07 |
0.06 |
0.07 |
0.06 |
0.08 |
0.08 |
0.08 |
| Operating Income Ratio
|
0.04
|
0.05
|
0.05
|
0.05
|
0.05
|
0.02
|
0.05
|
0.06
|
0.06
|
0.06
|
| Total Other
Income/Expenses Net |
-$2.57 B
|
-$2.12 B
|
-$2.77 B
|
-$4.14 B
|
-$2.99 B
|
-$2.62 B
|
-$1.27 B
|
-$1.75 B
|
-$859.00 M
|
-$1.12 B
|
| Income Before Tax |
$11.17 B |
$5.84 B |
$10.54 B |
$9.77 B |
$9.00 B |
$1.41 B |
$8.27 B |
$8.64 B |
$8.62 B |
$7.68 B |
| Income Before Tax Ratio
|
0.03
|
0.02
|
0.04
|
0.04
|
0.04
|
0.01
|
0.04
|
0.05
|
0.06
|
0.06
|
| Income Tax Expense |
$2.81 B |
$1.51 B |
$2.55 B |
$2.57 B |
$2.37 B |
$2.00 B |
$1.64 B |
$3.32 B |
$3.39 B |
$3.03 B |
| Net Income |
$8.34 B |
$4.31 B |
$8.00 B |
$7.18 B |
$6.63 B |
-$594.00 M |
$6.62 B |
$5.32 B |
$5.24 B |
$4.64 B |
| Net Income Ratio |
0.02 |
0.01 |
0.03 |
0.03 |
0.03 |
-0 |
0.04 |
0.03 |
0.03 |
0.03 |
| EPS |
6.49 |
3.29 |
6 |
5.48 |
5.1 |
-0.57 |
6.47 |
4.93 |
4.66 |
3.98 |
| EPS Diluted |
6.47 |
3.26 |
5.95 |
5.46 |
5.08 |
-0.57 |
6.44 |
4.9 |
4.63 |
3.96 |
| Weighted Average Shares
Out |
$1.29 B
|
$1.31 B
|
$1.32 B
|
$1.31 B
|
$1.30 B
|
$1.04 B
|
$1.02 B
|
$1.07 B
|
$1.12 B
|
$1.16 B
|
| Weighted Average Shares
Out Diluted |
$1.29 B
|
$1.32 B
|
$1.33 B
|
$1.31 B
|
$1.31 B
|
$1.04 B
|
$1.02 B
|
$1.08 B
|
$1.13 B
|
$1.17 B
|
| Link |
|
|
|
|
|
|
|
|
|
|
